The participants of the 2019 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.
In this report, you will find the key research take-away messages and the Learning Institute’s group reflections on the topics listed below that were presented at the Summit for Cancer Immunotherapy in October 2019:
- Immunotherapy 101
- Gene Editing in Cancer Immunotherapy
- Highlighting BioCanRx Clinical Trials
- Patient Plenary- Innovation, Access, and Affordability
- Brain Cancer Immunotherapy